EEG, activity, and sleep architecture in a transgenic AβPP swe/PSEN1A246E Alzheimer's disease mouse

Journal of Alzheimer's Disease

Volumn 22, Issue 3, 2010, Pages 873-887

  Jyoti, Amar ^a   Plano, Andrea ^a   Riedel, Gernot ^a   Platt, Bettina ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Alzheimer's disease; amyloid; circadian activity; EEG; FFT; power spectrum; presenilin; sleep

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ALERTNESS; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; GENOTYPE; HIPPOCAMPUS THETA RHYTHM; MICROCHIP ANALYSIS; MOUSE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; REM SLEEP; SLEEP; TRANSGENIC MOUSE; WAKEFULNESS; WILD TYPE;

EID: 78650644126     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100879     Document Type: Article

References (51)

1. Bliwise DL (2004) Sleep disorders in Alzheimer's disease and other dementias. Clin Cornerstone 6, S16-28.
2. McCurry SM, Reynolds CF, Ancoli-Israel S, Teri L, Vitiello MV (2000) Treatment of sleep disturbance in Alzheimer's disease. Sleep Med Rev 4, 603-628.
3. Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A (2001) Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry 158, 704-711.
4. Hegerl U, Moller HJ (1997) Electroencephalography as a diagnostic instrument in Alzheimer's disease: reviews and perspectives. IntPsychogeriatr 9, 237-46.
5. Bennys K, Rondouin G, Vergnes C, Touchon J (2001) Diagnostic value of quantitative EEG in Alzheimer's disease. Neurophysiol Clin 31, 153-160.
6. Liddell BJ, Paul RH, Arns M, Gordon N, Kukla M, Rowe D, Cooper N, Moyle J, Williams LM (2007) Rates of decline distinguish Alzheimer's disease and mild cognitive impairment relative to normal aging: integrating cognition and brain function. J Integr Neurosci 6, 141-174.
7. Kwak YT (2006) Quantitative EEG findings in different stages of Alzheimer's disease. J Clin Neurophysiol 23, 456-461.
8. Grunwald M, Busse F, Hensel A, Kruggel F, Riedel-Heller S, Wolf H, Arendt T, Gertz HJ (2001) Correlation between cortical theta activity and hippocampal volumes in health, mild cognitive impairment, and mild dementia. J Clin Neurophysiol 18, 178-184.
9. Jackson CE, Snyder PJ (2008) Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease. Alzheimers Dement 4, S137-143.
10. Prichep LS, John ER, Ferris SH, Reisberg B, Almas M, Alper K, Cancro R (1994) Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiol Aging 15, 85-90.
11. Babiloni C, Frisoni G, Steriade M, Bresciani L, Binetti G, Del Percio C, Geroldi C, Miniussi C, Nobili F, Rodriguez G, Zap- pasodi F, Carfagna T,Rossini PM (2006) Frontal white matter volume and delta EEG sources negatively correlate in awake subjects with mild cognitive impairment and Alzheimer's disease. Clin Neurophysiol 117, 1113-1129.
12. Vitiello MV, Borson S (2001) Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment. CNSDrugs 15, 777-796.
13. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA , Copeland NG, Price DL, Sisodia SS (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945.
14. Puolivali J, Wang J, Heikkinen T, Heikkila M, Tapiola T, van Groen T, Tanila H (2002) Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice. Neurobiol Dis 9, 339-347.
15. Liu L, Ikonen S, Heikkinen T, Heikkila M, Puolivali J, van Groen T, Tanila H (2002) Effects of fimbria-fornix lesion and amyloid pathology on spatial learning and memory in trans- genic APP+PS1 mice. Behav Brain Res 134, 433-445.
16. Filali M, Lalonde R, Rivest S (2009) Cognitive and non- cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease. Genes Brain Behav 8, 143-148.
17. Filali M, Lalonde R. Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease. Brain Res 1292, 93-99.
18. Gureviciene I, Ikonen S, Gurevicius K, Sarkaki A, van Groen T, Pussinen R, Ylinen A, Tanila H (2004) Normal induction but accelerated decay of LTP in APP + PS1 transgenic mice. NeurobiolDis 15, 188-195.
19. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K (1998) Accelerated Alzheimer-type phe- notype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4, 97-100.
20. Lalonde R, Kim HD, Maxwell JA, Fukuchi K (2005) Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/DeltaE9 mice with amyloid plaques. Neurosci Lett 390, 87-92.
21. Games D, Buttini M, Kobayashi D, Schenk D, Seubert P (2006) Mice as models: transgenic approaches and Alzheimer's disease. J Alzheimers Dis 9,133-149.
22. Wisor JP, Edgar DM, Yesavage J, Ryan HS, McCormick CM, Lapustea N, Murphy GM Jr (2005) Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission. Neuroscience 131, 375-385.
23. Huitron-Resendiz S, Sanchez-Alavez M, Gallegos R, Berg G, Crawford E, Giacchino JL, Games D, Henriksen SJ, Criado JR (2002) Age-independent and age-related deficits in visuospa- tial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res 928, 126-137.
24. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG, Sisodia SS (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013.
25. Franklin KBJ, Paxinos G (2008) The Mouse Brain in Stereotaxic Coordinates, Compact 3rd. Academic Press, Sydney.
26. Megevand P, Quairiaux C, Lascano AM, Kiss JZ, Michel CM (2008) A mouse model for studying large-scale neuronal networks using EEG mapping techniques. Neuroimage 42, 591602.
27. Riedel G, Fadda P, McKillop-Smith S, Pertwee RG, Platt B, Robinson L (2009) Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice. Br J Pharmacol 156, 1154-66.
28. Sunderam S, Chernyy N, Peixoto N, Mason JP, Weinstein SL, Schiff SJ, Gluckman BJ (2007) Improved sleep-wake and behavior discrimination using MEMS accelerometers. J Neurosci Methods 163, 373-383.
29. Backhaus J, Born J, Hoeckesfeld R, Fokuhl S, Hohagen F, Junghanns K (2007) Midlife decline in declarative memory consolidation is correlated with a decline in slow wave sleep. Learn Mem 14, 336-341.
30. Moe KE, Vitiello MV, Larsen LH, Prinz PN (1995) Symposium: Cognitive processes and sleep disturbances: Sleep/wake patterns in Alzheimer's disease: relationships with cognition and function. J Sleep Res 4, 15-20.
31. McCurry SM, Logsdon RG, Teri L, Gibbons LE, Kukull WA, Bowen JD, McCormick WC, Larson EB (1999) Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients. J Geriatr Psychiatry Neurol 12, 53-59.
32. Maquet P (2001) The role of sleep in learning and memory. Science 294, 1048-1052.
33. Peigneux P, Laureys S, Delbeuck X, Maquet P (2001) Sleeping brain, learning brain. The role of sleep for memory systems. Neuroreport 12, A111-24.
34. Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL (1988) The neu- ropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 24, 233-242.
35. Aletrino MA, Vogels OJ, Van Domburg PH, Ten Donkelaar HJ (1992) Cell loss in the nucleus raphes dorsalis in Alzheimer's disease. Neurobiol Aging 13, 461-468.
36. O'Neil JN, Mouton PR, Tizabi Y, Ottinger MA, Lei DL, Ingram DK, Manaye KF (2007) Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice. J Chem Neuroanat 34, 102-107.
37. van der Hiele K, Vein AA, van der Welle A, van der Grond J, Westendorp RG, Bollen EL, van Buchem MA, van Dijk JG, Middelkoop HA (2007) EEG and MRI correlates of mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 28, 1322-1329.
38. Wang J, Ikonen S, Gurevicius K, van Groen T, Tanila H (2002) Alteration of cortical EEG in mice carrying mutated human APP transgene. Brain Res 943, 181-190.
39. Mok SS, Clippingdale AB, Beyreuther K, Masters CL, Barrow CJ, Small DH (2000) A beta peptides and calcium influence secretion of the amyloid protein precursor from chick sympathetic neurons in culture. J Neurosci Res 61, 449-457.
40. Zhang C, Wu B, Beglopoulos V, Wines-Samuelson M, Zhang D, Dragatsis I, Sudhof TC, Shen J (2007) Presenilins are essential for regulating neurotransmitter release. Nature 460, 632-636.
41. Dierks T, Perisic I, Frolich L, Ihl R, Maurer K (1991) Topography of the quantitative electroencephalogram in dementia of the Alzheimer type: relation to severity of dementia. Psychiatry Res 40, 181-194.
42. Duffy FH, McAnulty GB, Albert MS (1993) The pattern of age-related differences in electrophysiological activity of healthy males and females. Neurobiol Aging 14, 73-84.
43. Hooijer C, Jonker C, Posthuma J, Visser SL (1990) Reliability, validity and follow-up of the EEG in senile dementia: sequelae of sequential measurement. Electroencephalogr Clin Neurophysiol 76, 400-412.
44. Helkala EL, Laulumaa V, Soikkeli R, Partanen J, Soininen H, Riekkinen PJ (1991) Slow-wave activity in the spectral analysis of the electroencephalogram is associated with cortical dysfunctions in patients with Alzheimer's disease. Behav Neurosci 105, 409-415.
45. Sloan EP, Fenton GW (1993) EEG power spectra and cognitive change in geriatric psychiatry: a longitudinal study. Electroencephalogr Clin Neurophysiol 86, 361-367.
46. Rodriguez G, Nobili F, Arrigo A, Priano F, De Carli F, Fran- cione S, Gambaro M, Rosadini G (1996) Prognostic significance of quantitative electroencephalography in Alzheimer patients: preliminary observations. Electroencephalogr Clin Neurophysiol 99, 123-128.
47. Petit D, Montplaisir J, Lorrain D, Gauthier S (1992) Spectral analysis of the rapid eye movement sleep electroencephalogram in right and left temporal regions: a biological marker of Alzheimer's disease. Ann Neurol 32, 172-176.
48. Petit D, Lorrain D, Gauthier S, Montplaisir J (1993) Regional spectral analysis of the REM sleep EEG in mild to moderate Alzheimer's disease. Neurobiol Aging 14, 141-145.
49. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003) Amyloid deposition precedes tangle formation in a triple transgenic model ofAlzheimer's disease. Neurobiol Aging 24, 1063-1070.
50. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 26, 1012910140.
51. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield J.P, Haroutunian V, Buxbaum J.D, Xu H (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156 15-20.